587
Views
2
CrossRef citations to date
0
Altmetric
Articles

Explaining institutional change in international patent politics

Bibliography

  • Abbott, F. M., and J. H. Reichman. “The Doha Round’s Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended trips Provisions.” Journal of International Economic Law 10, no. 4 (2007): 921–987.
  • Abbott, F. M., C. M. Correa, and P. Drahos. “Emerging Markets and the World Patent Order: The Forces of Change.” In Emerging Markets and the World Patent Order, edited by F. M. Abbott, C. M. Correa, and P. Drahos, 3–33. Cheltenham: Edward Elgar, 2013.
  • Alter, K. J., and S. Meunier. “Nested and Overlapping Regimes in the Transatlantic Banana Trade Dispute.” Journal of European Public Policy 13, no. 3 (2006): 362–382.
  • Alter, K. J., and S. Meunier. “The Politics of International Regime Complexity.” Perspectives on Politics 7, no. 1 (2009): 13–24.
  • Andersen, R. Governing Agrobiodiversity: Plant Genetics and Developing Countries. Aldershot: Ashgate, 2008.
  • Arkinstall, J., M. Childs, L. Menghaney, N. Ford, and T. von Schoen-Angerer. “The Reality Behind the Rhetoric: How European Policies Risk Harming Access to Generic Medicines in Developing Countries.” Journal of Generic Medicines 8, no. 1 (2011): 14–22.
  • Berger, M. T. “After the Third World? History, Destiny and the Fate of Third Worldism.” Third World Quarterly 25, no. 1 (2004): 9–39.
  • Biermann, F., P. Pattberg, H. van Asselt, and F. Zelli. “The Fragmentation of Global Governance Architectures: A Framework for Analysis.” Global Environmental Politics 9, no. 4 (2009): 14–38.
  • Brand, U., C. Görg, J. Hirsch, and M. Wissen. Conflicts in Environmental Regulation and the Internationalisation of the State: Contested Terrains. London: Routledge, 2008.
  • Busch, M. L. “Overlapping Institutions, Forum Shopping, and Dispute Settlement in International Trade.” International Organization 61, no. 4 (2007): 735–761.
  • Carmody, P. “Another bric in the Wall? South Africa’s Developmental Impact and Contradictory Rise in Africa and Beyond.” European Journal of Development Research 24, no. 2 (2012): 223–241.
  • Colgan, J. D., R. O. Keohane, and T. van der Graaf. “Punctuated Equilibrium in the Energy Regime Complex.” Review of International Organizations 7, no. 2 (2011): 117–143.
  • Cooper, H. D. “The International Treaty on Plant Genetic Resources for Food and Agriculture.” Review of European Community and International Environmental Law 11, no. 1 (2002): 1–16.
  • Cullet, P. “Intellectual Property Rights and Food Security in the South.” Journal of World Intellectual Property 7, no. 3 (2004): 261–286.
  • de Beer, J. “Defining wipo’s Development Agenda.” In Implementing wipo’s Development Agenda, Chapter 1. Ottawa: Wilfrid Laurier University Press.
  • dnd Working Group. Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases. Geneva: Médecins Sans Frontières Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group, 2001.
  • El Said, M. K. “The European trips-plus Model and the Arab World: From Co-operation to Association, New Era in the Global iprs Regime?” Liverpool Law Review 28, no. 1 (2007): 143–174.
  • etc Group. Putting the Cartel before the Horse: Who will Control Agricultural Inputs? Ottawa: Action Group on Erosion, Technology and Concentration, 2013.
  • European Union. “Strategy for the Enforcement of Intellectual Property Rights in Third Countries.” Official Journal of the European Union, 2005/C 129/03.
  • Fidler, D. “Indonesia’s Decision to Withhold Influenza Virus Samples from the World Health Organization: Implications for International Law.” asil Insights 11, no. 4 (2007).
  • Flynn, S., M. Kaminski, B. K. Baker, and J. Koo. Public Interest Analysis of the US tpp Proposal for an ip Chapter. pijip Research Paper Series 21. Washington, 2011.
  • Frein, M., and H. Meyer. Das abc des abs-Regimes: Biopiraterie und die Verhandlungen auf dem Weg nach Nagoya. Bonn: Evangelischer Entwicklungsdienst, 2010.
  • Gerstetter, C., B. Görlach, K. Neumann, and D. Schaffrin. “The International Treaty on Plant Genetic Resources for Food and Agriculture within the Current Legal Regime Complex on Plant Genetic Resources.” Journal of World Intellectual Property 10, nos. 3–4 (2007): 259–283.
  • Haas, E. B. “Why Collaborate? Issue-linkage and International Regimes.” World Politics 32, no. 3 (1980): 357–405.
  • Helfer, L. R. “Regime Shifting in the International Intellectual Property System.” Perspectives on Politics 7, no. 1 (2009): 39–44.
  • Horn, H., P. C. Mavroidis, and A. Sapir. “Beyond the wto? An Anatomy of EU and US Preferential Trade Agreements.” The World Economy 33, no. 11 (2010): 1565–1588.
  • Jaeger, T. T. The EU Approach to ip Protection in Partnership Agreements. Max Planck Institute for Intellectual Property, Competition & Tax Law Research Paper 10-01. Munich, 2010.
  • Kale, D., and S. Little. “From Imitation to Innovation: The Evolution of r&d Capabilities and Learning Processes in the Indian Pharmaceutical Industry.” Technology Analysis & Strategic Management 19, no. 5 (2007): 589–609.
  • Keohane, R. O., and D. G. Victor. “The Regime Complex for Climate Change.” Perspectives on Politics 9, no. 1 (2011): 7–23.
  • Keukeleire, S., and B. Hooijmaaijers. “The brics and Other Emerging Power Alliances and Multilateral Organizations in the Asia-Pacific and the Global South: Challenges for the European Union and its View on Multilateralism.” JCMS: Journal of Common Market Studies. doi: 10.1111/jcms.12102.
  • Koskenniemi, M., and P. Leino. “Fragmentation of International Law? Postmodern Anxieties.” Leiden Journal of International Law 15, no. 3 (2002): 553–579.
  • Lawson, S., D. Heacock, and A. Stupnytska. “Beyond the brics: A Look at the ‘Next 11’.” In brics and Beyond, edited by J. O’Neill. Washington, DC: Goldman Sachs, 2007.
  • Leebron, D. W. “Linkages.” American Journal of International Law 96, no. 1 (2002): 5–27.
  • Li, X. wco secure: Lessons Learnt from the Abortion of the trips-plus-plus ip Enforcement Initiative. South Center Research Paper 19. Geneva, 2008.
  • Médecins Sans Frontières. “A Blank Cheque for Abuse: The Anti-Counterfeiting Trade Agreement (acta) and its Impact on Access to Medicines.” msf Briefing Document, 2012.
  • Mercurio, B. “Beyond the Text: The Significance of the Anti-Counterfeiting Trade Agreement.” Journal of International Economic Law 15, no. 2 (2012): 361–390.
  • Mgbeoji, I. Global Biopiracy: Patents, Plants and Indigenous Knowledge. Vancouver: University of British Columbia Press, 2006.
  • Moore, G., and W. Tymowski. Explanatory Guide to the International Treaty on Plant Genetic Resources for Food and Agriculture. iucn Environmental Policy and Law Paper 57. Gland, Switzerland and Cambridge, UK, 2005.
  • Morin, J. F. “Multilateralizing trips-plus Agreements: Is the US Strategy a Failure?” Journal of World Intellectual Property 12, no. 3 (2009): 175–197.
  • Morse, J. C., and R. O. Keohane. “Contested Multilateralism.” Review of International Organizations. doi:10.1007/s11558-014-9188-2.
  • Muzaka, V. “Linkages, Contests and Overlaps in the Global Intellectual Property Rights Regime.” European Journal of International Relations 17, no. 4 (2011): 755–776.
  • Narlikar, A., and D. Tussie. “The G20 at the Cancun Ministerial: Developing Countries and their Evolving Coalitions in the wto.” The World Economy 27, no. 7 (2004): 947–966.
  • Niosi, J., P. Hanel, and S. Reid. “The International Diffusion of Biotechnology: The Arrival of Developing Countries.” Journal of Evolutionary Economics 22, no. 4 (2012): 767–783.
  • Oberthür, S., and O. S. Stokke. “Conclusions: Decentralized Interplay Management in an Evolving Interinstitutional Order.” In Managing Institutional Complexity: Regime Interplay and Global Environmental Change, edited by S. Oberthür and O. S. Stokke, 313–342. Cambridge, MA: mit Press, 2011.
  • O’Neill, J. Building Better Global Economic brics. Goldman Sachs Global Economics Paper 66. Washington, DC, 2001.
  • O’Neill, J., D. Wilson, R. Purushothaman, and A. Stupnytska. How Solid are the brics? Goldman Sachs Global Economics Paper 134. Washington, DC, 2005.
  • Orsini, A., J. F. Morin, and O. R. Young. “Regime Complexes: A Buzz, a Boom, or a Boost for Global Governance?” Global Governance 19, no. 1 (2013): 27–39.
  • Oxfam. Eye on the Ball: Medicine Regulation – not ip Enforcement – can best Deliver Quality Medicines. Oxfam Briefing Paper 143. Oxford: Oxfam, 2011.
  • Raustiala, K., and D. G. Victor. “The Regime Complex for Plant Genetic Resources.” International Organization 58, no. 2 (2004): 277–309.
  • Robinson, D. Confronting Biopiracy: Challenges, Cases and International Debates. Abingdon: Routledge, 2010.
  • Robinson, D., and C. Gibson. “Governing Knowledge: Discourses and Tactics of the European Union in Trade-related Intellectual Property Negotiations.” Antipode 43, no. 5 (2011): 1883–1910.
  • Roffe, P., and C. Spennemann. “The Impact of ftas on Public Health Policies and trips Flexibilities.” International Journal of Intellectual Property Management 1, nos. 1–2 (2006): 75–93.
  • Rosendal, K. The Convention on Biological Diversity and Developing Countries. Dordrecht: Springer, 2000.
  • Sedyaningsih, E. R., S. Isfandari, T. Soendoro, and S. F. Supari. “Towards Mutual Trust, Transparency and Equity in Virus Sharing Mechanism [sic]: The Avian Influenza Case of Indonesia.” Annals of the Medical Academy of Singapore, no. 37 (2008): 482–488.
  • Sell, S. K. The Global ip Upward Ratchet, Anti-counterfeiting and Piracy Enforcement Efforts: The State of Play. pijip Research Paper 15. Washington, 2010.
  • Sell, S. K. “trips was Never Enough: Vertical Forum Shifting, ftas, acta, and tpp.” Journal of Intellectual Property Law 18, no. 2 (2010): 447–478.
  • Seuba, X. “Intellectual Property in Preferential Trade Agreements: What Treaties, What Content?” Journal of World Intellectual Property 16, nos. 5–6 (2013): 240–261.
  • Shiva, V. Biopiracy: The Plunder of Nature and Knowledge. Cambridge, MA: South End Press, 1999.
  • Thach, S., and S. J. Marsnik. “Patent Standards under trips and the Pharmaceutical Industries in Brazil and India.” Latin American Business Review 10, no. 4 (2009): 237–261.
  • Third World Network. “The EU–India Free Trade Agreement and Access to Medicines.” Third World Resurgence, no. 259 (2012).
  • ‘t Hoen, E. F. M. “trips, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond.” Chicago Journal of International Law 3, no. 1 (2002): 27–46.
  • unctad. The Least Developed Countries Report 2012. New York: United Nations Conference on Trade and Development, 2012.
  • Van Asselt, H., and F. Zelli. “Introduction: The Institutional Fragmentation of Global Environmental Governance – Causes, Consequences, and Responses.” Global Environmental Politics 13, no. 3 (2013): 1–13.
  • Velasquez, G. The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. South Centre Research Paper 35. Geneva, 2011.
  • Wallbott, L., F. Wolff, and J. Pozarowska. “The Negotiations of the Nagoya Protocol: Issues, Coalitions, and Process.” In Global Governance of Genetic Resources: Access and Benefit Sharing after the Nagoya Protocol, edited by S. Oberthür and K. Rosendal, 33–59. Abingdon: Routledge, 2014.
  • Weinstock Netanel, N. “Introduction: The wipo Development Agenda and its Development Policy Context.” In The Development Agenda: Global Intellectual Property and Developing Countries, edited by N. Weinstock Netanel. Oxford: Oxford University Press, 2008.
  • Xibao, L. “Behind the Recent Surge of Chinese Patenting: An Institutional View.” Research Policy 41, no. 1 (2012): 236–249.
  • Young, O. R. “Institutional Linkages in International Society: Polar Perspectives.” Global Governance 2 (1996): 1–24.
  • Zylberberg, E., C. Zylberberg, and A. C. Oner. “Biotechnology in Brazil: An Industry Overview.” Journal of Commercial Biotechnology 18, no. 4 (2012): 9–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.